Cargando…

Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report

Detalles Bibliográficos
Autores principales: Schüller, Hannah, Klein, Franziska, Lübbert, Michael, Prager, Eric Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652905/
https://www.ncbi.nlm.nih.gov/pubmed/33170342
http://dx.doi.org/10.1007/s00277-020-04318-6
_version_ 1783607792297312256
author Schüller, Hannah
Klein, Franziska
Lübbert, Michael
Prager, Eric Peter
author_facet Schüller, Hannah
Klein, Franziska
Lübbert, Michael
Prager, Eric Peter
author_sort Schüller, Hannah
collection PubMed
description
format Online
Article
Text
id pubmed-7652905
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-76529052020-11-10 Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report Schüller, Hannah Klein, Franziska Lübbert, Michael Prager, Eric Peter Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2020-11-10 2021 /pmc/articles/PMC7652905/ /pubmed/33170342 http://dx.doi.org/10.1007/s00277-020-04318-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Schüller, Hannah
Klein, Franziska
Lübbert, Michael
Prager, Eric Peter
Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report
title Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report
title_full Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report
title_fullStr Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report
title_full_unstemmed Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report
title_short Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report
title_sort hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by sars-cov-2 (covid-19): a case report
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652905/
https://www.ncbi.nlm.nih.gov/pubmed/33170342
http://dx.doi.org/10.1007/s00277-020-04318-6
work_keys_str_mv AT schullerhannah hemolyticcrisisinapatienttreatedwitheculizumabforparoxysmalnocturnalhemoglobinuriapossiblytriggeredbysarscov2covid19acasereport
AT kleinfranziska hemolyticcrisisinapatienttreatedwitheculizumabforparoxysmalnocturnalhemoglobinuriapossiblytriggeredbysarscov2covid19acasereport
AT lubbertmichael hemolyticcrisisinapatienttreatedwitheculizumabforparoxysmalnocturnalhemoglobinuriapossiblytriggeredbysarscov2covid19acasereport
AT pragerericpeter hemolyticcrisisinapatienttreatedwitheculizumabforparoxysmalnocturnalhemoglobinuriapossiblytriggeredbysarscov2covid19acasereport